Apararenone
Modify Date: 2024-01-02 09:35:33
Apararenone structure
|
Common Name | Apararenone | ||
|---|---|---|---|---|
| CAS Number | 945966-46-1 | Molecular Weight | 364.391 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 594.3±60.0 °C at 760 mmHg | |
| Molecular Formula | C17H17FN2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 313.2±32.9 °C | |
Use of ApararenoneApararenone (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis. |
| Name | Apararenone |
|---|---|
| Synonym | More Synonyms |
| Description | Apararenone (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis. |
|---|---|
| Related Catalog | |
| Target |
Mineralocorticoid receptor[1] |
| In Vivo | Recently, a phase II clinical trial has been initiated among patients with non-alcoholic steatohepatitis (NASH) in Japan[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 594.3±60.0 °C at 760 mmHg |
| Molecular Formula | C17H17FN2O4S |
| Molecular Weight | 364.391 |
| Flash Point | 313.2±32.9 °C |
| Exact Mass | 364.089294 |
| LogP | 1.26 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.610 |
| Storage condition | 2-8℃ |
| Methanesulfonamide, N-[4-(4-fluorophenyl)-3,4-dihydro-2,2-dimethyl-3-oxo-2H-1,4-benzoxazin-7-yl]- |
| UNII:832663U2NB |
| 832663U2NB |
| N-[4-(4-Fluorophenyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl]methanesulfonamide |
| apararenone |